Machado NK, Leyva MAM, Alonso SK, Hernández PJR, Labarta RDM

Language: Spanish
References: 10
Page: 1-9
PDF size: 360.78 Kb.

ABSTRACT

A 53- year- old patient diagnosed with type I diabetes mellitus, of Jose Avila Serrano Polyclinic health area of Teaching Polyclinic of Velasco was presented in this paper. The patient initially was admitted to Lucia Iñiguez Landin Surgical Hospital of Holguin with the diagnosis of neuroinfectious diabetic foot complicated with an abscess. Antibiotic treatment was given as well as Heberprot-P, with an application cycle of a bulb (0.75 mg) every other day for four weeks. From the fourth and fifth dose, the patient´s progress was satisfactory, a good granulation was observed. The pain disappeared and the lesion cicatrized.

REFERENCES

1. Rivero Fernández FE, Vejerano García P, Fernández Montequin JI, Lazo Díaz I. Programa de prevención del pie diabético e introducción del uso del Heberprot-P en atención primaria. Rev Cub Angiol Cir Vasc .2009. [citado 10 nov 2012];10 (1): 3-11. Disponible en: http://bvs.sld.cu/revistas/ang/vol10_1_09/ang04109.htm

2. González C, Baldomero J, Pérez LM, Paredes N, Hernández AR, Campos E, et al. Tratamiento con Heberprot-P. Presentación de caso. Biotecnología Aplicada. 2010. [citado 10 nov 2012]; 27(2):110. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000200014&nrm=iso

3. Vuolo J. Why people with diabetes suffer foot ulceration? Nurs Times. 2007; 103 (15):44-6.

4. Wilson DJ. Amputation and diabetes foot: Learning from a case study. BJCN. 2005.10; 155 (12 suppl): 518524.

5. Reparas Asencio L, Sánchez García Cervigón P. El pie Diabético. An Med Int. 2004; 21:416-9.

6. Kats LA. A randomized trial of two irremovable off-loading deices in the management of plantar neuropathia diabetic foot ulcers. Diabet Care. 2005; 28:555-9.

7. Veves A, Gurini J. (Ed).The Diabetic Foot. 2 ed. Boston: Humana Press; 2006.

8. Margolis DJ, Bartus C, Hoffstad O, Malay S, Berlin JA .Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers. Wound Repair Regen; 2005.

9. Berlanga IJ, Fernández M, López E, López PA, del Río A, et al. Heberprot-P: A novel product for treating advanced diabetic foot ulcer. MEDICC Review. 2013 [citado 12 feb 2013]; 15(1): Disponible en: http://www.medicc.org/mediccreview/index.php?issue=23&id=287&a=va

10. García Herrera AL, Cantero Calderón S, Vázquez Díaz O, Jiménez Pérez MJ, Acosta Cabadilla L, Rodríguez Hernández L, et al. Evaluación de la eficacia y seguridad del Heberprot- p con dos diluentes en el tratamiento del pie diabético. Rev Esp Invest Quirurg. 2012; 15 (1):3-8.